Shandong Huihai Pharmaceutical & Chemical Co., Ltd. Sustainability Profile
Shandong Huihai Pharmaceutical & Chemical Co., Ltd., commonly referred to as Huihai, is a prominent player in the pharmaceutical and chemical industry, headquartered in Shandong, China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical intermediates and active pharmaceutical ingredients (APIs), catering to both domestic and international markets. With a strong focus on research and innovation, Huihai offers a diverse range of products, including APIs for various therapeutic areas, which are distinguished by their purity and efficacy. The company has achieved notable recognition for its commitment to quality and compliance with international standards, positioning itself as a trusted supplier in the global pharmaceutical landscape. Through continuous investment in technology and sustainable practices, Shandong Huihai Pharmaceutical & Chemical Co., Ltd. remains dedicated to advancing healthcare solutions worldwide.
DitchCarbon Score
How does Shandong Huihai Pharmaceutical & Chemical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shandong Huihai Pharmaceutical & Chemical Co., Ltd.'s score of 5 is lower than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shandong Huihai Pharmaceutical & Chemical Co., Ltd.'s reported carbon emissions
In 2023, Shandong Huihai Pharmaceutical & Chemical Co., Ltd. reported total carbon emissions of approximately 762,000 kg CO2e for Scope 1 and about 592,000 kg CO2e for Scope 2. This data highlights the company's direct and indirect emissions from its operations. Notably, there is no reported data for Scope 3 emissions, which typically encompass the entire value chain. Despite the emissions data, Shandong Huihai has not established any specific reduction targets or climate pledges, indicating a potential area for improvement in their sustainability strategy. The absence of Science-Based Targets Initiative (SBTi) commitments further underscores the need for a more robust climate action framework. Overall, while the company has disclosed its emissions for 2023, it lacks significant reduction initiatives or commitments, which are essential for aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 762,000 |
| Scope 2 | 592,000 |
| Scope 3 | - |
How Carbon Intensive is Shandong Huihai Pharmaceutical & Chemical Co., Ltd.'s Industry?
How Carbon Intensive is Shandong Huihai Pharmaceutical & Chemical Co., Ltd.'s Location?
Shandong Huihai Pharmaceutical & Chemical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shandong Huihai Pharmaceutical & Chemical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
